<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>lisnorway</title>
		<link>http://www.lisnorway.no/</link>
		<atom:link href="http://www.lisnorway.no/sider/rss.asp" rel="self" type="application/rss+xml" />
		<description>RSS generert av eRedaktor</description>
		<language>no</language>
		<generator>eRedaktor</generator>
		<item>
			<title>LIS anbefalinger 2012 MS</title>
			<link>http://www.lisnorway.no/sider/tekst.asp?side=51</link>
			<description></description>
			<pubDate>26.01.2012</pubDate>
			<author>nospam@www.lisnorway.no ( )</author>
			<category>Aktuelt</category>
			<guid>http://www.lisnorway.no/sider/tekst.asp?side=51</guid>
		</item>
		<item>
			<title>LIS anbefalinger 2012 TNF/BIO</title>
			<link>http://www.lisnorway.no/sider/tekst.asp?side=50</link>
			<description></description>
			<pubDate>26.01.2012</pubDate>
			<author>nospam@www.lisnorway.no ( )</author>
			<category>Aktuelt</category>
			<guid>http://www.lisnorway.no/sider/tekst.asp?side=50</guid>
		</item>
		<item>
			<title>RHFenes informasjonspakke biologiske- og MS-legemidler 5. april 2011</title>
			<link>http://www.lisnorway.no/sider/tekst.asp?side=44</link>
			<description></description>
			<pubDate>25.01.2012</pubDate>
			<author>nospam@www.lisnorway.no ( )</author>
			<category>Aktuelt</category>
			<guid>http://www.lisnorway.no/sider/tekst.asp?side=44</guid>
		</item>
		<item>
			<title>TLV: </title>
			<link>http://www.lisnorway.no/sider/tekst.asp?side=49</link>
			<description>TNF-h&#228;mmare kvarst&#229;r i h&#246;gkostnadsskyddet</description>
			<pubDate>20.12.2011</pubDate>
			<author>nospam@www.lisnorway.no ( )</author>
			<category>Aktuelt</category>
			<guid>http://www.lisnorway.no/sider/tekst.asp?side=49</guid>
		</item>
		<item>
			<title>LIS TNF/BIO anbefalinger og LIS MS-anbefalinger 2011</title>
			<link>http://www.lisnorway.no/sider/tekst.asp?side=48</link>
			<description></description>
			<pubDate>15.04.2011</pubDate>
			<author>nospam@www.lisnorway.no ( )</author>
			<category>Aktuelt</category>
			<guid>http://www.lisnorway.no/sider/tekst.asp?side=48</guid>
		</item>
		<item>
			<title>LIS bidrar til lave legemiddelpriser</title>
			<link>http://www.lisnorway.no/sider/tekst.asp?side=47</link>
			<description>LIS bidrar til lave legemiddelpriser</description>
			<pubDate>07.04.2011</pubDate>
			<author>nospam@www.lisnorway.no ( )</author>
			<category>Aktuelt</category>
			<guid>http://www.lisnorway.no/sider/tekst.asp?side=47</guid>
		</item>
		<item>
			<title>LIS-avtaler Biologiske legemidler 2010</title>
			<link>http://www.lisnorway.no/sider/tekst.asp?side=46</link>
			<description></description>
			<pubDate>17.09.2010</pubDate>
			<author>nospam@www.lisnorway.no ( )</author>
			<category>Aktuelt</category>
			<guid>http://www.lisnorway.no/sider/tekst.asp?side=46</guid>
		</item>
		<item>
			<title>Industriseminar 27. april 2010</title>
			<link>http://www.lisnorway.no/sider/tekst.asp?side=45</link>
			<description></description>
			<pubDate>18.03.2010</pubDate>
			<author>nospam@www.lisnorway.no ( )</author>
			<category>Aktuelt</category>
			<guid>http://www.lisnorway.no/sider/tekst.asp?side=45</guid>
		</item>
		<item>
			<title>Dagens Medicin: Nyt udvalg skal skaffe rabatter p&#229; dyr sygehusmedicin</title>
			<link>http://www.lisnorway.no/sider/tekst.asp?side=43</link>
			<description>Dagens Medicin: Nyt udvalg skal skaffe rabatter p&#229; dyr sygehusmedicin</description>
			<pubDate>10.11.2009</pubDate>
			<author>nospam@www.lisnorway.no ( )</author>
			<category>Aktuelt</category>
			<guid>http://www.lisnorway.no/sider/tekst.asp?side=43</guid>
		</item>
		<item>
			<title>Evaluering av effekter av endringer i finansieringsansvaret for TNF-hemmere</title>
			<link>http://www.lisnorway.no/sider/tekst.asp?side=42</link>
			<description></description>
			<pubDate>19.10.2009</pubDate>
			<author>nospam@www.lisnorway.no ( )</author>
			<category>Aktuelt</category>
			<guid>http://www.lisnorway.no/sider/tekst.asp?side=42</guid>
		</item>
		<item>
			<title>Informasjonsm&#248;te ang&#229;ende tilbudskonkurranse LIS MS 1003</title>
			<link>http://www.lisnorway.no/sider/tekst.asp?side=41</link>
			<description></description>
			<pubDate>07.10.2009</pubDate>
			<author>nospam@www.lisnorway.no ( )</author>
			<category>Aktuelt</category>
			<guid>http://www.lisnorway.no/sider/tekst.asp?side=41</guid>
		</item>
		<item>
			<title>Innkj&#248;psforum</title>
			<link>http://www.lisnorway.no/sider/tekst.asp?side=40</link>
			<description></description>
			<pubDate>18.06.2009</pubDate>
			<author>nospam@www.lisnorway.no ( )</author>
			<category>Aktuelt</category>
			<guid>http://www.lisnorway.no/sider/tekst.asp?side=40</guid>
		</item>
		<item>
			<title>Priser p&#229; sykehuslegemidler i Danmark - rapport</title>
			<link>http://www.lisnorway.no/sider/tekst.asp?side=39</link>
			<description></description>
			<pubDate>27.05.2009</pubDate>
			<author>nospam@www.lisnorway.no ( )</author>
			<category>Aktuelt</category>
			<guid>http://www.lisnorway.no/sider/tekst.asp?side=39</guid>
		</item>
		<item>
			<title>Nytt fra Sykehusapoteket i Midt-Norge HF</title>
			<link>http://www.lisnorway.no/sider/tekst.asp?side=38</link>
			<description></description>
			<pubDate>03.04.2009</pubDate>
			<author>nospam@www.lisnorway.no ( )</author>
			<category>Aktuelt</category>
			<guid>http://www.lisnorway.no/sider/tekst.asp?side=38</guid>
		</item>
	</channel>
</rss>

